Simultaneous determination of haloperidol and bromperidol and their reduced metabolites by liquid–liquid extraction and automated column-switching high-performance liquid chromatography
- 1 June 2004
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B
- Vol. 805 (1) , 175-180
- https://doi.org/10.1016/j.jchromb.2004.02.043
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Use of antipsychotic agents in Spain through 1985–2000European Psychiatry, 2002
- Comparison of Two High-Performance Liquid Chromatographic Methods for Monitoring Plasma Concentrations of Haloperidol and Reduced HaloperidolTherapeutic Drug Monitoring, 1998
- Prolactin Response to Bromperidol Treatment in Schizophrenic PatientsBasic & Clinical Pharmacology & Toxicology, 1998
- Blood levels of reduced halopertool versus clinical efficacy and extrapyramidal side effects of haloperidolProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1997
- Reduced haloperidol: a factor in determining the therapeutic benefit of haloperidol treatment?Psychopharmacology, 1992
- Simultaneous determination of haloperidol and its metabolite, reduced haloperidol, in plasma, blood, urine and tissue homogenates by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1991
- Pharmacokinetics of HaloperidolClinical Pharmacokinetics, 1989
- An Improved Sensitive Assay for Simultaneous Determination of Plasma Haloperidol and Reduced Haloperidol Levels by Liquid Chromatography Using a Coulometric DetectorTherapeutic Drug Monitoring, 1989
- Determination of bromperidol in serum by automated column-switching high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1989
- Plasma Level Monitoring of Antipsychotic Drugs Clinical UtilityClinical Pharmacokinetics, 1986